MUDr. David Šálek

2024

• Outcome of patients with diffuse large B-cell lymphoma and testicular involvement - real world data

  MOCIKOVA Heidi JANÍKOVÁ Andrea SYKOROVA Alice PROCHAZKA Vit PIRNOS Jan DURAS Juraj KOPECKOVA Katerina STEINEROVA Katerina PYTLIK Robert BLAHOVCOVA Petra ŠÁLEK David KOZAK Tomas BACHANOVA Veronika BELADA David

  Article in Periodical

  Annals of Hematology, year: 2024, DOI

2019

• ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients

  MAREČKOVÁ Andrea MALČÍKOVÁ Jitka TOM Nikola PÁL Karol RADOVÁ Lenka ŠÁLEK David JANÍKOVÁ Andrea MOULIS Mojmír ŠMARDOVÁ Jana KŘEN Leoš MAYER Jiří TRBUŠEK Martin

  Article in Periodical

  LEUKEMIA & LYMPHOMA, year: 2019, volume: 60, edition: 6, DOI

• Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation

  KLENER Pavel ŠÁLEK David PYTLIK Robert MOCIKOVA Heidi FORSTEROVA Kristina BLAHOVCOVA Petra CAMPR Vit PROCHAZKA Vit OBR Ales JAKSA Radek KUNTSCHEROVA Jana BOUDOVA Ludmila KODET Roman JANÍKOVÁ Andrea TRNENY Marek

  Article in Periodical

  American Journal of Hematology, year: 2019, volume: 94, edition: 2, DOI

2018

• Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma

  KLENER Pavel FRONKOVA Eva BELADA David FORSTEROVA Kristina PYTLIK Robert KALINOVA Marketa SIMKOVIC Martin ŠÁLEK David MOCIKOVA Heidi PROCHAZKA Vít BLAHOVCOVA Petra JANÍKOVÁ Andrea MARKOVA Jana OBR Ales BERKOVA Adela KUBINYI Jozef VASKOVA Martina MEJSTRIKOVA Ester CAMPR Vít JAKSA Radek KODET Roman MICHALOVA Kyra TRKA Jan TRNENY Marek

  Article in Periodical

  Hematological Oncology, year: 2018, volume: 36, edition: 1, DOI

• Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance

  KLENER Pavel FRONKOVA Eva KALINOVA Marketa BELADA David FORSTEROVA Kristina PYTLIK Robert BLAHOVCOVA Petra SIMKOVIC Martin ŠÁLEK David MOCIKOVA Heidi PROCHAZKA Vit JANIKOVA Andrea VASKOVA Martina MEJSTRIKOVA Ester KODET Roman TRKA Jan TRNENY Marek

  Article in Periodical

  Hematological Oncology, year: 2018, volume: 36, edition: 5, DOI

2017

• Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas

  ZLÁMALÍKOVÁ Lenka MOULIS Mojmír RAVČUKOVÁ Barbora LIŠKOVÁ Květoslava MALČÍKOVÁ Jitka ŠÁLEK David JARKOVSKÝ Jiří SVITÁKOVÁ Miluše HRABÁLKOVÁ Renata ŠMARDA Jan ŠMARDOVÁ Jana

  Article in Periodical

  Oncology Reports, year: 2017, volume: 38, edition: 4, DOI

• Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database

  PROCHAZKA V. PAPAJIK T. JANÍKOVÁ Andrea BELADA D. KOZAK T. ŠÁLEK David SYKOROVA A. MOCIKOVA H. CAMPR V. DLOUHA J. LANGOVA K. FURST T. TRNENY M.

  Article in Periodical

  LEUKEMIA & LYMPHOMA, year: 2017, volume: 58, edition: 3, DOI

2016

• ATM gene mutations represent a hallmark of mantle cell lymphoma but do not impact patients survival.

  MAREČKOVÁ Andrea MALČÍKOVÁ Jitka TOM Nikola PÁL Karol ŠÁLEK David POSPÍŠILOVÁ Šárka TRBUŠEK Martin

  Conference abstract

  Year: 2016, type: Conference abstract

• Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas

  ZLÁMALÍKOVÁ Lenka MOULIS Mojmír ŠÁLEK David JARKOVSKÝ Jiří ŠMARDA Jan ŠMARDOVÁ Jana

  Article in Periodical

  Oncology Reports, year: 2016, volume: 35, edition: 5, DOI

• Hodnocení klinického stadia a léčebné odpovědi u maligních lymfomů – doporučení Kooperativní lymfomové skupiny na základě revidovaných kritérií z roku 2014 (Luganská klasifikace)

  SÝKOROVÁ A. PYTLÍK R. MÓCIKOVÁ H. BELADA D. BENEŠOVÁ K. PAPAJÍK T. JANÍKOVÁ Andrea ŠÁLEK David PROCHÁZKA V. VOKURKA S. CAMPR V. KLENER P. KUBÁČKOVÁ K. TRNĚNÝ M.

  Article in Periodical

  Klinická onkologie, year: 2016, volume: 29, edition: 4, DOI